{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:41:01Z","timestamp":1792687261342,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","award":["7026-00027B"],"award-info":[{"award-number":["7026-00027B"]}],"id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011958","name":"Danmarks Frie Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011958","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["675370"],"award-info":[{"award-number":["675370"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["H2020-MSCA-ITN-2015"],"award-info":[{"award-number":["H2020-MSCA-ITN-2015"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/j.jconrel.2021.12.008","type":"journal-article","created":{"date-parts":[[2021,12,9]],"date-time":"2021-12-09T20:41:01Z","timestamp":1639082461000},"page":"388-399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"special_numbering":"C","title":["The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency"],"prefix":"10.1016","volume":"342","author":[{"given":"Giulia","family":"Anderluzzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustavo","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe Tandrup","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Gallorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Brazzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig W.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek T.","family":"O'Hagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara C.","family":"Baudner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Perrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2021.12.008_bb0005","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1080\/14760584.2017.1355245","article-title":"Mechanism of action of mRNA-based vaccines","volume":"16","author":"Iavarone","year":"2017","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0010","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/j.omtn.2019.08.001","article-title":"Expression kinetics and innate immune response after electroporation and LNP-mediated delivery of a self-amplifying mRNA in the skin","volume":"17","author":"Huysmans","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0015","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ymthe.2017.11.017","article-title":"Self-amplifying RNA vaccines give equivalent protection against influenza to mRNA vaccines but at much lower doses","volume":"26","author":"Vogel","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0020","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.ymthe.2019.01.020","article-title":"mRNA as a transformative technology for vaccine development to control infectious diseases","volume":"27","author":"Maruggi","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0025","doi-asserted-by":"crossref","first-page":"3523","DOI":"10.1038\/s41467-020-17409-9","article-title":"Self-amplifying RNA SARS-CoV-2 lipid nanoparticle vaccine candidate induces high neutralizing antibody titers in mice","volume":"11","author":"McKay","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0030","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3390\/vaccines9020097","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0035","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s41541-017-0032-6","article-title":"Unmodified mRNA in LNPs constitutes a competitive technology for prophylactic vaccines","volume":"2","author":"Lutz","year":"2017","journal-title":"Npj Vaccines."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0040","doi-asserted-by":"crossref","first-page":"2118","DOI":"10.1038\/mt.2014.133","article-title":"A cationic Nanoemulsion for the delivery of next-generation RNA vaccines","volume":"22","author":"Brito","year":"2014","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0045","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1016\/j.cell.2017.02.017","article-title":"Modified mRNA vaccines protect against Zika virus infection","volume":"168","author":"Richner","year":"2017","journal-title":"Cell."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0050","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM \u00ae vaccine against H7N9 influenza is immunogenic in mice","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0055","doi-asserted-by":"crossref","first-page":"14604","DOI":"10.1073\/pnas.1209367109","article-title":"Nonviral delivery of self-amplifying RNA vaccines","volume":"109","author":"Geall","year":"2012","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0060","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/s41434-019-0095-2","article-title":"Inside out: optimization of lipid nanoparticle formulations for exterior complexation and in vivo delivery of saRNA","volume":"26","author":"Blakney","year":"2019","journal-title":"Gene Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0065","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1016\/j.vaccine.2012.04.060","article-title":"RNA-based vaccines","volume":"30","author":"Ulmer","year":"2012","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0070","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1021\/acsinfecdis.9b00084","article-title":"Mannosylation of LNP results in improved potency for self-amplifying RNA (SAM) vaccines","volume":"5","author":"Goswami","year":"2019","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0075","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1016\/j.ymthe.2017.08.006","article-title":"Efficient targeting and activation of antigen-presenting cells in vivo after modified mRNA vaccine administration in Rhesus Macaques","volume":"25","author":"Liang","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0080","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines \u2014 a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0085","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s00262-016-1869-7","article-title":"Uptake of synthetic naked RNA by skin-resident dendritic cells via macropinocytosis allows antigen expression and induction of T-cell responses in mice","volume":"65","author":"Selmi","year":"2016","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0090","first-page":"3","article-title":"Concepts in Mucosal Immunity and Mucosal Vaccines","author":"Gallorini","year":"2014"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0095","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.jconrel.2016.02.043","article-title":"Enhanced intranasal delivery of mRNA vaccine by overcoming the nasal epithelial barrier via intra- and paracellular pathways","volume":"228","author":"Li","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0100","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3390\/vaccines8020212","article-title":"Investigating the impact of delivery system design on the efficacy of self-amplifying RNA vaccines","volume":"8","author":"Anderluzzi","year":"2020","journal-title":"Vaccines."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0105","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jconrel.2020.06.027","article-title":"Delivery of self-amplifying mRNA vaccines by cationic lipid nanoparticles: the impact of cationic lipid selection","volume":"325","author":"Lou","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0110","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.1016\/j.vaccine.2006.12.012","article-title":"Multicenter comparative study of a new ELISA, PLATELIATM RABIES II, for the detection and titration of anti-rabies glycoprotein antibodies and comparison with the rapid fluorescent focus inhibition test (RFFIT) on human samples from vaccinated and non-vacc","volume":"25","author":"Feyssaguet","year":"2007","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0115","first-page":"281","article-title":"Vaccination against rabies and protective antibodies - comparison of ELISA and fluorescent antibody virus neutralization (FAVN) assays","volume":"76","author":"Stantj","year":"2006","journal-title":"Vet. Arh."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0120","doi-asserted-by":"crossref","first-page":"2382","DOI":"10.1016\/j.vaccine.2013.12.043","article-title":"Sublingual immunization with a subunit influenza vaccine elicits comparable systemic immune response as intramuscular immunization, but also induces local IgA and TH17 responses","volume":"32","author":"Gallorini","year":"2014","journal-title":"Vaccine."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0125","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jconrel.2020.04.001","article-title":"Design of a novel vaccine nanotechnology-based delivery system comprising CpGODN-protein conjugate anchored to liposomes","volume":"323","author":"Chatzikleanthous","year":"2020","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0130","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.3390\/pharmaceutics12111095","article-title":"Manufacturing considerations for the development of lipid nanoparticles using microfluidics","volume":"12","author":"Roces","year":"2020","journal-title":"Pharmaceutics."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0135","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1016\/j.jconrel.2020.10.066","article-title":"Rational design of adjuvants for subunit vaccines: the format of cationic adjuvants affects the induction of antigen-specific antibody responses","volume":"330","author":"Anderluzzi","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0140","doi-asserted-by":"crossref","first-page":"4787","DOI":"10.1021\/acsnano.8b01516","article-title":"On the formation and morphology of lipid nanoparticles containing Ionizable cationic lipids and siRNA","volume":"12","author":"Kulkarni","year":"2018","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.matdes.2020.108805","article-title":"Review of hybrid PLGA nanoparticles: future of smart drug delivery and theranostics medicine","volume":"193","author":"Ghitman","year":"2020","journal-title":"Mater. Des."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0150","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.omtn.2019.01.013","article-title":"Optimization of lipid nanoparticles for intramuscular administration of mRNA vaccines","volume":"15","author":"Hassett","year":"2019","journal-title":"Mol. Ther. - Nucleic Acids."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0155","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jconrel.2021.05.021","article-title":"Impact of lipid nanoparticle size on mRNA vaccine immunogenicity","volume":"335","author":"Hassett","year":"2021","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0160","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.ymthe.2019.02.012","article-title":"Delivering the messenger: advances in technologies for therapeutic mRNA delivery","volume":"27","author":"Kowalski","year":"2019","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0165","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/j.ymthe.2017.03.013","article-title":"Lipid nanoparticle systems for enabling gene therapies","volume":"25","author":"Cullis","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0170","doi-asserted-by":"crossref","first-page":"5711","DOI":"10.1021\/acsnano.0c00326","article-title":"Big is beautiful: enhanced saRNA delivery and immunogenicity by a higher molecular weight, bioreducible, cationic polymer","volume":"14","author":"Blakney","year":"2020","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0175","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1086\/589862","article-title":"Vaccines: correlates of vaccine-induced immunity","volume":"47","author":"Plotkin","year":"2008","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0180","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.ejpb.2018.05.009","article-title":"Recent advances in carrier mediated nose-to-brain delivery of pharmaceutics","volume":"128","author":"Bourganis","year":"2018","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0185","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1111\/imm.12505","article-title":"CD8 T-cell priming upon mRNA vaccination is restricted to bone-marrow-derived antigen-presenting cells and may involve antigen transfer from myocytes","volume":"146","author":"Lazzaro","year":"2015","journal-title":"Immunology."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0190","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1586\/erv.10.49","article-title":"New flow cytometric assays for monitoring cell-mediated cytotoxicity","volume":"9","author":"Zaritskaya","year":"2010","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0195","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cellimm.2008.08.007","article-title":"Relationship between CD107a expression and cytotoxic activity","volume":"254","author":"Aktas","year":"2009","journal-title":"Cell. Immunol."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0200","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/s41551-019-0378-3","article-title":"Visualization of early events in mRNA vaccine delivery in non-human primates via PET\u2013CT and near-infrared imaging","volume":"3","author":"Lindsay","year":"2019","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0205","doi-asserted-by":"crossref","first-page":"67","DOI":"10.4161\/hv.8.1.18419","article-title":"Current evidence on intradermal influenza vaccines administered by SoluviaTM licensed micro injection system","volume":"8","author":"Icardi","year":"2012","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0210","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1586\/14760584.2015.1011134","article-title":"30 years of rabies vaccination with Rabipur: a summary of clinical data and global experience","volume":"14","author":"Giesen","year":"2015","journal-title":"Expert Rev. Vaccines."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0215","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1080\/21645515.2015.1010871","article-title":"Intradermal vaccination using the novel microneedle device MicronJet600: past, present, and future","volume":"11","author":"Levin","year":"2015","journal-title":"Hum. Vaccin. Immunother."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0220","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00483","article-title":"Fatty acids, lipid mediators, and T-cell function","volume":"5","author":"de Jong","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0225","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.3390\/nu11122990","article-title":"The influence of dietary fatty acids on immune responses","volume":"11","author":"Radzikowska","year":"2019","journal-title":"Nutrients."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0230","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.bbrc.2006.05.159","article-title":"Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation","volume":"346","author":"Stentz","year":"2006","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0235","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.jconrel.2015.08.007","article-title":"Expression kinetics of nucleoside-modified mRNA delivered in lipid nanoparticles to mice by various routes","volume":"217","author":"Pardi","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2021.12.008_bb0240","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.ejpb.2015.11.003","article-title":"Mucoadhesive vs. mucopenetrating particulate drug delivery","volume":"98","author":"Netsomboon","year":"2016","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0245","doi-asserted-by":"crossref","first-page":"667","DOI":"10.2217\/17460913.2.6.667","article-title":"Use of animal models in the development of human vaccines","volume":"2","author":"Gerdts","year":"2007","journal-title":"Future Microbiol."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0250","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1038\/mt.2010.85","article-title":"Targeted delivery of RNAi therapeutics with endogenous and exogenous ligand-based mechanisms","volume":"18","author":"Akinc","year":"2010","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0255","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.ijpharm.2016.06.124","article-title":"Structure, activity and uptake mechanism of siRNA-lipid nanoparticles with an asymmetric ionizable lipid","volume":"510","author":"Suzuki","year":"2016","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2021.12.008_bb0260","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1161\/ATVBAHA.108.179564","article-title":"The LDL receptor","volume":"29","author":"Goldstein","year":"2009","journal-title":"Arterioscler. Thromb. Vasc. Biol."}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006593?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365921006593?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T12:07:33Z","timestamp":1778674053000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365921006593"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":52,"alternative-id":["S0168365921006593"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.008","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of nanoparticle format and route of administration on self-amplifying mRNA vaccine potency","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2021.12.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}